Study Explores Modification of Psychedelic Drug to Retain Therapeutic Benefits

A recent study explores the potential modification of a psychedelic drug to retain therapeutic benefits while eliminating psychedelic effects. By targeting the serotonin 1A receptor, researchers aim to develop modified drugs for treating psychiatric illnesses like depression and PTSD.